Synchronous Presence of EGFR, ALK Driver Mutations Along With PD L1 Overexpression in a Resected Early Stage Non-Small Cell Lung Cancer: A Case Report and Review of Literature

Treatment of lung cancer has been revolutionized with development of drugs that target key driver mutations and immune checkpoints. Until recently, it was believed that these driver mutations are mutually exclusive. However, few reports have emerged citing the presence of both mutations either synch...

Descripción completa

Detalles Bibliográficos
Autores principales: Thumallapally, Nishitha, Parylo, Sara, Vennepureddy, Adarsh, Ibrahim, Uroosa, Sokoloff, Alisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942208/
https://www.ncbi.nlm.nih.gov/pubmed/29760833
http://dx.doi.org/10.14740/wjon1090e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942208/
https://www.ncbi.nlm.nih.gov/pubmed/29760833
http://dx.doi.org/10.14740/wjon1090e

Ejemplares similares